Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

Medical treatment for rectovaginal endometriosis: what is the evidence?

Vercellini, P., Crosignani, P. G., Somigliana, E., Berlanda, N., Barbara, G., Fedele, L. · 2009 · Human Reproduction

Abstract

Background Rectovaginal endometriosis usually causes distressing pain. Surgical treatment may be effective but is associated with a high risk of morbidity and major complications. Information on the effect of medical alternatives for pain relief in this condition is scarce. Methods A comprehensive literature search was conducted to identify all the English language published observational and randomized studies evaluating the efficacy of medical treatments on pain associated with rectovaginal endometriosis. A combination of keywords was used to identify relevant citations in PubMed, MEDLINE and EMBASE. Results A total of 217 cases of medically treated rectovaginal endometriosis were found; 68 in five observational, non-comparative studies, 59 in one patient preference cohort study, and 90 in a randomized controlled trial. An aromatase inhibitor was used in two of the non-comparative studies, vaginal danazol in one, a GnRH agonist in one, and an intrauterine progestin in one. Two estrogen-progestin combinations used transvaginally or transdermally were evaluated in the patient preference study, whereas an oral progestin and an estrogen-progestin combination were compared in the randomized controlled trial. With the exception of an aromatase inhibitor used alone, the antalgic effect of the considered medical therapies was high for the entire treatment period (from 6 to 12 months), with 60-90% of patients reporting considerable reduction or complete relief from pain symptoms. Co…

Overview

Integrity signals

Registry

Crossref · 10.1093/humrep/dep231

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 56 references

Research works printed but not linked: 5

  1. 2007, 75, 134
  2. 1997, Acta obstetricia et gynecologica Scandinavica, 76, 30
  3. 1996, Human Reproduction, 10, 2263
  4. 2008, Fertility and sterility, 90, 260
  5. 2004, The Journal of the American Association of Gynecologic Laparoscopists, 11, 127

Cited by

See all 144

Metadata

Authors
Vercellini, P., Crosignani, P. G., Somigliana, E., Berlanda, N., Barbara, G., & Fedele, L.
Affiliations
  • University of Milan (IT)
  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
Corresponding author
Vercellini, P.
Venue
Human Reproduction
Published
2009-07-02
Volume
24
Issue
10
Pages
2504-2514
ISSN
  • 0268-1161 (ISSN-L)
  • 1460-2350
OpenAlex
W2128286983
Cited by
144
References
56
Citations by year
2026: 3 · 2025: 4 · 2024: 8 · 2022: 2 · 2021: 8 · 2020: 8 · 2019: 7 · 2018: 11 · 2017: 15 · 2016: 8 · 2015: 5 · 2014: 10 · 2013: 11 · 2012: 14
FWCI
2.07
Type
journal article
Language
en
Open access
closed
Locations
  • Human Reproduction (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
Keywords
rectovaginal endometriosis, medical treatment, analgesia, aromatase inhibitors, danazol, GnRH agonist, progestins, estrogen-progestin combination, endometriosis-associated pain
MeSH terms
Anastrozole, Danazol, Endometriosis, Female, Humans, Intrauterine Devices, Gonadotropin-Releasing Hormone, Nitriles, Pain, Rectal Diseases, Triazoles, Vaginal Diseases, Cohort Studies, Randomized Controlled Trials as Topic, Treatment Outcome, Levonorgestrel, Aromatase Inhibitors, Patient Preference

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Medical treatment for rectovaginal endometriosis: what is the evidence? https://app.cochat.ai/papers/10.1093/humrep/dep231
The paper
Vercellini, P., Crosignani, P. G., Somigliana, E., Berlanda, N., Barbara, G., & Fedele, L. (2009). Medical treatment for rectovaginal endometriosis: what is the evidence? Human Reproduction. https://doi.org/10.1093/humrep/dep231

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.